GALK2 anticorps (AA 141-240) (AbBy Fluor® 647)

N° du produit ABIN1699473

Cet anticorps anti-GALK2 est un anticorps Lapin Polyclonal détectant GALK2 dans WB, IF (cc) et IF (p). Adapté pour Rat.

Aperçu rapide pour GALK2 anticorps (AA 141-240) (AbBy Fluor® 647) (ABIN1699473)

Antigène: GALK2 (Galactokinase 2 (GALK2))

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GALK2 est conjugé à/à la AbBy Fluor® 647

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-GALK2 anticorps (AbBy Fluor® 647)

Épitope: AA 141-240

Réactivité croisée: Rat

Homologie: Human,Mouse,Dog,Cow,Sheep,Pig,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human GALK2/Galactokinase 2

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur GALK2

Antigène: GALK2 (Galactokinase 2 (GALK2))

Autre désignation: GALK2/Galactokinase 2

Sujet:

Synonyms: GaINAc Kinase, Galactokinase 2, GALK2, GK2, MGC1745, N-acetylgalactosamine kinase, GALK2_HUMAN.

Background: GALK2 is important in the first step of the galactose metabolism pathway. GALK1, which belongs to the GHMP kinase family of proteins, is a crucial enzyme for galactose metabolism, specifically converting ?d-galactose to galactose 1-phosphate. Defects in the gene encoding GALK1 can cause galactosemia II, an autosomal recessive disorder characterized by congenital cataracts during infancy, often within the first two weeks of life. In the adult population, galactosemia II can cause presenile cataracts that are secondary to accumulation of galactitol in the lens of the eye. A second gene, GALK2, encodes an enzyme with greater activity against GalNAc than galactose. GALK2 has been implicated in the salvage pathway for the reutilization of free GalNAc derived from the degradation of complex carbohydrates.

ID gène: 2585